A case report of mesalazine-induced lung injury: A reversible drug side effect

ConclusionsMesalazine-induced HP has been scarcely described in the literature. This Case indicates that HP is a rare but real entity in UC patients on continuous oral mesalazine treatment; its possibility should also be considered when unexplained respiratory symptoms develop during therapy. Amelioration of symptoms, imaging, and lung function improvement seem to occur only upon the abrupt drug discontinuation.
Source: Respiratory Medicine Case Reports - Category: Respiratory Medicine Source Type: research